The increasing rate of pet ownership worldwide, along with a rise in spending on animal healthcare is expected to fuel market growth. For instance, the American Pet Products Association reported a significant increase in U.S. pet ownership with over 66% of households owning pets in 2023. Furthermore, the growing favorable pet insurance is contributing to market growth. For instance, the North American Pet Health Insurance Association's (NAPHIA) 2023 reported a 124.9% surge in insured pets since 2018, reaching over 4.8 million by 2022. Thus, the growing pet ownership coupled with favorable pet insurance policies are expected to ease the financial burden on pet owners, thereby driving anticipated market expansion in the foreseeable future.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Market size for veterinary ear infection treatment was valued at USD 1.2 billion in 2023 and is expected to reach USD 2 billion by 2032, driven by rising pet adoption rate, and increasing awareness regarding veterinary health.
Prescription medicine segment held a decent market share in 2023 and is set to gain prominence through 2032, as ear infections in animals vary widely in severity and underlying causes, necessitating tailored treatment approaches that often require prescription medications.
North America veterinary ear infection treatment market is expected to reach USD 728.8 million by 2032, due to the increasing awareness about pet health and rising expenditure on animal healthcare.
Baye AG, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Merck & Co., Inc., Penn Veterinary Supply, Inc., Piedmont Animal Health, Inc., Vedco, Inc, Vetnique Labs., Vetoquinol S.A are some of the major industry contenders.